Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Chun WangZhaomei MuZhong YeZhenchao ZhangMaysa M Abu-KhalafDaniel P SilverJuan P PalazzoGeetha JagannathanFrederick M FellinSaveri BhattacharyaRebecca J JaslowTheodore N TsangarisAdam BergerManish NeupaneTerrence P CesconAnaMaria LopezKaelan YaoWeelic ChongBrian LuRonald E MyersLifang HouQiang WeiBingshan LiMassimo CristofanilliHushan YangPublished in: Breast cancer research and treatment (2020)
In advanced-stage breast cancer patients with tHER2- tumors, cHER2 status has the potential to guide the use of anti-HER2 targeted therapy in patients with high-risk cHER2.